fda warning bpc-157 unapproved drug marketing warning letter The growing popularity of peptides, many of which have not been authorized by the Food and Administration, prompted Alabama's medical board to warn against prescribing them. (Full story below.) FDA warning letters target marketers

Under these conditions, lyophilized peptide maintains potency for years

For scientific research use only

This includes a comprehensive review of your medical history, current medications, allergies, and any underlying health conditions that may impact your treatment

However, the short elimination half-life of BPC-157 means even split dosing doesnt maintain truly constant levels

Simulation of the kratom-midazolam interaction using mitragynine as a surrogate for kratom showed an ~1.25-fold increase in AUC and ~1.2-fold increase in C max for midazolam (Figure 4), which were ~1520% lower than the observed values

Consulting with a healthcare professional before starting any supplementation regimen is highly recommended